Clinical TrialsSearch results
Number of results: 918
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Completed
- Drug-Drug interaction study of AJM300(1)
- Combination clinical pharmacology study of oral midazolam, oral prednisolone, oral atorvastatin and intravenous midazolam in healthy male subjects -
- Ulcerative Colitis
- Takeuchi Yutaka
- 2023-06-19
Completed
- ELEVATE UC 40 JAPAN: Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Japanese Subjects
- Ulcerative colitis
- IQVIA Services Japan K.K. ICCC:
- 2021-01-13
Recruiting
- A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Ulcerative Colitis Crohn's Disease
- Shikamura Mitsuhiro
- 2023-07-05
Recruiting
- Effect of empagliflozin for HFpEF with Type2 DM
- Type2 DM
- Shiose Akira
- 2019-03-29
Other
- Clinical study of combinational therapy of AD-4833 with metformin -Phase III double-blind comparative study-
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-04-04
Other
- Post-marketing Clinical Trial of Pioglitazone - A Study of Preventive Effects on the Onset and Recurrence of Macrovascular Events -
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-09-10
Other
- Multicenter study for the effect preserving renal function of HMG-CoA reductase inhibitor (simvastatin) in type 2 diabetic nephropathy with hyperlipidemia (MIDN Study)
- Type 2 diabetic nephropathy with hyperlipidemia
- Japanese Society of Kidney and Lipids
- 2006-03-27
Other
- Kyushu pitavastatin and pravastatin Intervention trial on Diabetic NEphropathY
- Type 2 diabetic nephropathy with Hypercholesterolemia
- Kyushu University Graduate School of Medical Science Department of Medicine and Bioregulatory Science
- 2008-08-22
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01